Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Lubniewski Insider Profile
4 Followers
John Lubniewski, President & CEO, Director at HTG Molecular Diagnostics, holds 157.53K shares in HTG Molecular Diagnostics (Ticker: HTGM).
John Lubniewski has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John Lubniewski's holdings
Insider Roles
President & CEO, Director
Roles that John Lubniewski holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 12, 2015 - Aug 12, 2016
Return:-69.10%
The most profitable trade made by John Lubniewski
John Lubniewski's Trading History
List of latest transactions for each holding click on a transaction to see John Lubniewski's performance on stock
You May Also Like
John Lubniewski insider profile FAQ
What is the percentage of profitable transactions made by John Lubniewski?
The percentage of profitable transactions made by John Lubniewski is ―.
What is the average return per transaction made by John Lubniewski?
The average return per transaction made by John Lubniewski is ―.
What stocks does John Lubniewski hold?
John Lubniewski holds: HTGM stocks.
What was John Lubniewski’s latest transaction?
John Lubniewski latest transaction was an Uninformative Sell of $303.93.
What was John Lubniewski's most profitable transaction?
John Lubniewski’s most profitable transaction was an Informative Buy of HTGM stock on August 12, 2015. The return on the trade was -69.10%.
What is John Lubniewski's role in HTG Molecular Diagnostics?
John Lubniewski's role in HTG Molecular Diagnostics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.